Loncar Cancer Immunotherapy ETF logo

Loncar Cancer Immunotherapy ETF (CNCR)

Delisted
27 May 2025
NASDAQ (NGS) NASDAQ (NGS)
$
9. 02
+0.14
+1.5766%
$
7.04M Market Cap
- P/E Ratio
7.41% Div Yield
3,077 Volume
- Eps
$ 8.88
Previous Close
Day Range
9.02 9.41
Year Range
7.88 16.27
Want to track CNCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Ex-Dividend Date Dividend Payment Date Record Date Declaration Date Frequency
Loncar Cancer Immunotherapy ETF logo
CNCR Paid
Loncar Cancer Immunotherapy ETF
31 Dec 2021
29 Dec 2021
$1.85
31 Dec 2021
30 Dec 2021
28 Dec 2021
Annual
Loncar Cancer Immunotherapy ETF logo
CNCR Paid
Loncar Cancer Immunotherapy ETF
4 Jan 2021
30 Dec 2020
$0.29
4 Jan 2021
31 Dec 2020
29 Dec 2020
Annual
Loncar Cancer Immunotherapy ETF logo
CNCR Paid
Loncar Cancer Immunotherapy ETF
2 Jan 2018
28 Dec 2017
$0.23
2 Jan 2018
29 Dec 2017
27 Dec 2017
Annual
Loncar Cancer Immunotherapy ETF logo
CNCR Paid
Loncar Cancer Immunotherapy ETF
4 Jan 2016
29 Dec 2015
$0.08
4 Jan 2016
31 Dec 2015
28 Dec 2015
Annual